Nirvana Life Sciences Inc.
Nirvana Life Sciences Inc.
CSE Index:
Currency:
Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.
Nirvana Life Sciences Inc. (NIRV)
SEDAR Information
Company Info
Address
Suite 2110, 650 West Georgia Street
Vancouver, BC V6B 4N8
CanadaPhone
(604) 401-8100Email
Info@nirvanalifescience.comWebsite
https://nirvanalifescience.comListing date
Thursday, March 17, 2022Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
33020139Reserved for Issuance:
300000News Releases
10/10/2023
MCTO Update
Bulletins
05/09/2024
2024-0903 - Suspension - Nirvana Life Sciences Inc. (NIRV)
le 5 septembre/September 2024
Effective immediately, Nirvana Life Sciences Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the British Columbia Securities Commission
For more information about Cease Trade Orders, visit the Canadian Securities Administrators Cease Trade Order database at www.securities-administrators.ca.
